The Joint Committee on Vaccination and Immunisation (JCVI) has considered the evidence for Phase 2 of the UK’s COVID-19 vaccination programme. Category: UncategorisedBy 26 February 2021Leave a commentPost navigationPreviousPrevious post:Consultation outcome: Proposed changes to how smoking-attributable risk is calculatedNextNext post:Guidance: COVID-19 vaccination: information for healthcare practitioners
